STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PTC Therapeutics (NASDAQ: PTCT) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 8:35 a.m. ET, the Wells Fargo Healthcare Conference on September 4 at 11:00 a.m. ET, and the Morgan Stanley Global Healthcare Conference on September 8 at 9:15 a.m. ET.

All presentations will be available via webcast on PTC's investor relations website and will remain accessible for 30 days after each event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.14% News Effect

On the day this news was published, PTCT gained 0.14%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Aug. 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

Cantor Global Healthcare Conference 2025
Wednesday, Sept. 3 at 8:35 a.m. ET

Wells Fargo 2025 Healthcare Conference
Thursday, Sept. 4 at 11:00 a.m. ET

Morgan Stanley 23rd Annual Global Healthcare Conference
Monday, Sept. 8 at 9:15 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes before the start of the webcast to ensure a timely connection.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

For More Information:

Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com 

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302535211.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics (PTCT) presenting at the Cantor Global Healthcare Conference 2025?

PTC Therapeutics will present at the Cantor Global Healthcare Conference on Wednesday, September 3, 2025, at 8:35 a.m. ET.

How can investors access PTC Therapeutics' conference presentations in September 2025?

Investors can access the presentations via live webcast on PTC's investor relations website at ir.ptcbio.com/events-presentations. The webcasts will be archived for 30 days following each presentation.

What investor conferences is PTC Therapeutics (PTCT) attending in September 2025?

PTC Therapeutics is attending three conferences: the Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), and Morgan Stanley Global Healthcare Conference (Sept 8).

What time is PTC Therapeutics presenting at the Morgan Stanley Healthcare Conference 2025?

PTC Therapeutics will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2025, at 9:15 a.m. ET.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.17B
78.27M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN